TABLE 2.
Treatment of patients with localized colorectal HGNEC and metastatic colorectal HGNEC (%)
| Treatments | Localized (N = 41) |
Metastatic (N = 85) |
||
|---|---|---|---|---|
| Anorectal (61 %) | Colonic (39 %) | Anorectal (38 %) | Colonic (62 %) | |
| Chemotherapy only | 9 | 0 | 60 | 32 |
| CRT only | 38 | 0 | ||
| Surgery only | 0 | 19 | ||
| CRT and chemotherapy | 27 | 0 | ||
| CRT and surgery | 24 | 0 | 3 | 0 |
| Chemotherapy and surgery | 0 | 9 | ||
| Surgery and chemotherapy | 19 | 81 | 10 | 60 |
| Surgery and CRT | 10 | 0 | ||
HGNEC high-grade neuroendocrine carcinoma, CRT chemoradiotherapy